-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to Q3 2025.
- NewAmsterdam Pharma Co N.V. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$72M, a 333% decline year-over-year.
- NewAmsterdam Pharma Co N.V. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$221M, a 11.1% decline year-over-year.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2024 was -$242M, a 36.5% decline from 2023.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2023 was -$177M, a 682% decline from 2022.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2022 was -$22.6M, a 45.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)